In endometrial cancer, uterine-infiltrating CD68+CD163+ macrophages induce ERα expression through IL-17A-mediated epigenetic mechanisms, sensitizing cancer cells to E2 and accelerating tumor progression 237. Here, ESR1 is linked to endometrial cancer.